Free Trial
NASDAQ:SMLR

Semler Scientific (SMLR) Stock Price, News & Analysis

Semler Scientific logo
$34.44 +0.16 (+0.47%)
As of 04/24/2025 04:00 PM Eastern

About Semler Scientific Stock (NASDAQ:SMLR)

Key Stats

Today's Range
$34.00
$35.20
50-Day Range
$29.83
$52.24
52-Week Range
$20.88
$81.56
Volume
142,805 shs
Average Volume
401,218 shs
Market Capitalization
$330.52 million
P/E Ratio
7.01
Dividend Yield
N/A
Price Target
$71.00
Consensus Rating
Buy

Company Overview

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Semler Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

SMLR MarketRank™: 

Semler Scientific scored higher than 52% of companies evaluated by MarketBeat, and ranked 311th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Semler Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Semler Scientific has received no research coverage in the past 90 days.

  • Read more about Semler Scientific's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Semler Scientific is 7.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Semler Scientific is 7.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.18.

  • Price to Book Value per Share Ratio

    Semler Scientific has a P/B Ratio of 3.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Semler Scientific's valuation and earnings.
  • Percentage of Shares Shorted

    23.04% of the float of Semler Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Semler Scientific has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Semler Scientific has recently increased by 20.13%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Semler Scientific does not currently pay a dividend.

  • Dividend Growth

    Semler Scientific does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    23.04% of the float of Semler Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Semler Scientific has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Semler Scientific has recently increased by 20.13%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Semler Scientific has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Semler Scientific this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for SMLR on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Semler Scientific insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    30.20% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    49.37% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Semler Scientific's insider trading history.
Receive SMLR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter.

SMLR Stock News Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
Semler Scientific files $500M mixed securities shelf
See More Headlines

SMLR Stock Analysis - Frequently Asked Questions

Semler Scientific's stock was trading at $54.00 on January 1st, 2025. Since then, SMLR shares have decreased by 36.2% and is now trading at $34.44.
View the best growth stocks for 2025 here
.

Semler Scientific, Inc. (NASDAQ:SMLR) posted its quarterly earnings results on Tuesday, February, 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $3.21. The business had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a trailing twelve-month return on equity of 50.77%.
Read the conference call transcript
.

Top institutional shareholders of Semler Scientific include Shariaportfolio Inc. (1.09%), Exchange Traded Concepts LLC (0.61%), Deltec Asset Management LLC (0.50%) and CWC Advisors LLC. (0.09%).
View institutional ownership trends
.

Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Semler Scientific investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Arista Networks (ANET) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
2/18/2025
Today
4/24/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SMLR
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$71.00
High Stock Price Target
$71.00
Low Stock Price Target
$71.00
Potential Upside/Downside
+106.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
7.01
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$20.58 million
Pretax Margin
30.75%

Debt

Sales & Book Value

Annual Sales
$56.29 million
Cash Flow
$2.03 per share
Price / Cash Flow
16.95
Book Value
$10.45 per share
Price / Book
3.30

Miscellaneous

Free Float
6,468,000
Market Cap
$330.52 million
Optionable
Not Optionable
Beta
1.29
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:SMLR) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners